Trademark Overview
On Monday, March 4, 2024, a trademark application was filed for ANGICYTE with the United States Patent and Trademark Office. The USPTO has given the ANGICYTE trademark a serial number of 79399244. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Monday, April 7, 2025. This trademark is owned by VASCVERSA LIMITED. The ANGICYTE trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for the treatment of ischemic diseases; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of ischemic diseases; Pharmaceutical preparations containing stem cells for the treatment of ischemic diseases and stimulation of vascular regeneration, blood vessel repair, and tissue revitalization; Stem cells for medical purposes; cells for medical use; cell growth media for growing cells for medical use; living cells for medical use; cellular function activating agents for medical purposes; Vaccines; Reagents for medical use; medical diagnostic reagents
Stem cells for research purposes; stem cells for scientific purposes; chemicals for use in manufacturing pharmaceuticals; reagents for research purposes; reagents for medical research; reagents for scientific purposes; diagnostic reagents for scientific or research use; cell culture reagents for scientific and research use; blood culture media for scientific use
Regenerative medicine services; medical services; stem cell therapy services; cell therapy services; Stem cell therapy services for vascular regeneration and repair; cell therapy services relating to the generation of human vascular reparative cells; cell therapy services relating to the injecting, grafting or implanting of cells into patients; medical services relating to the removal, treatment and processing of cells; Medical services relating to the removal, treatment and processing of stem cells; Stem cell storage, namely, stem cell bank services; Cultured cell bank services for medical transplantation; medical laboratory services for the analysis of samples taken from patients; Medical analysis services for the diagnosis and treatment of persons; Services for the testing of blood, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services relating to the removal, treatment and processing of human blood
Medical devices for the treatment of ischemic diseases and stimulation of vascular regeneration, blood vessel repair, and tissue revitalization; Medical apparatus and instruments for the treatment of ischemic diseases and stimulation of vascular regeneration, blood vessel repair, and tissue revitalization; Apparatus for the regeneration of stem cells for medical purposes; medical devices and apparatus for vascular regeneration and repair in the treatment of ischemic diseases; Medical devices and apparatus for cell therapy for the treatment of ischemic diseases and stimulation of vascular regeneration, blood vessel repair, and tissue revitalization; Blood testing apparatus
Medical and pharmacological research services; Stem cell research; Scientific research services for others relating to the isolation and cultivation of human tissues and cells; Research in the field of cell engineering technology; Scientific and medical research in the field of vascular regeneration and repair; Research and development of medicines; Pharmaceutical drug development services; Drug discovery services; Development of pharmaceutical preparations and medicines; Development of stem and progenitor cell therapies and other cell therapies; Research and development services in the medical field of cell therapy; research and development services in the medical field of vascular regeneration and repair; Scientific research in the nature of conducting clinical trials for others; Blood analysis services for scientific research purposes
